APS vs. LTY, BCT, HEM, CZO, SBM, REUN, NEPT, ATE, KNE, and RVX
Should you be buying Aptose Biosciences stock or one of its competitors? The main competitors of Aptose Biosciences include Liberty Biopharma (LTY), BriaCell Therapeutics (BCT), Hemostemix (HEM), Ceapro (CZO), Sirona Biochem (SBM), Reunion Neuroscience (REUN), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Kane Biotech (KNE), and Resverlogix (RVX). These companies are all part of the "biotechnology" industry.
Aptose Biosciences vs.
Aptose Biosciences (TSE:APS) and Liberty Biopharma (CVE:LTY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.
In the previous week, Aptose Biosciences' average media sentiment score of 0.00 equaled Liberty Biopharma'saverage media sentiment score.
Liberty Biopharma's return on equity of 0.00% beat Aptose Biosciences' return on equity.
Liberty Biopharma is trading at a lower price-to-earnings ratio than Aptose Biosciences, indicating that it is currently the more affordable of the two stocks.
Aptose Biosciences received 129 more outperform votes than Liberty Biopharma when rated by MarketBeat users. However, 72.81% of users gave Liberty Biopharma an outperform vote while only 72.11% of users gave Aptose Biosciences an outperform vote.
15.1% of Aptose Biosciences shares are held by institutional investors. 17.1% of Aptose Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Aptose Biosciences and Liberty Biopharma tied by winning 4 of the 8 factors compared between the two stocks.
Get Aptose Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptose Biosciences Competitors List
Related Companies and Tools
This page (TSE:APS) was last updated on 1/21/2025 by MarketBeat.com Staff
